Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study

Authors:

Abstract
Background/Aaims: Congenital stationary night blindness (CSNB) is an inherited retinal disease that is often associated with high myopia and can be caused by pathological variants in multiple genes, most commonly CACNA1F , NYX and TRPM1 . High myopia is associated with retinal degeneration and increased risk for retinal detachment. Slowing the progression of myopia in patients with CSNB would likely be beneficial in reducing risk, but before interventions can be considered, it is important to understand the natural history of myopic progression. Methods: This multicentre, retrospective study explored CSNB caused by variants in CACNA1F , NYX or TRPM1 in patients who had at least 6 measurements of their spherical equivalent of refraction (SER) before the age of 18. A mixed-effect model was used to predict progression of SER overtime and differences between genotypes were evaluated. Results: 78 individuals were included in this study. All genotypes showed a significant myopic predicted SER at birth (−3.076D, −5.511D and −5.386D) for CACNA1F , NYX and TRPM1 respectively. Additionally, significant progression of myopia per year (−0.254D, −0.257D and −0.326D) was observed for all three genotypes CACNA1F , NYX and TRPM1 , respectively. Conclusions: Patients with CSNB tend to be myopic from an early age and progress to become more myopic with age. Patients may benefit from long-term myopia slowing treatment in the future and further studies are indicated. Additionally, CSNB should be considered in the differential diagnosis for early-onset myopia.
Funding Information
  • Malcolm M. Marquis, MD Endowed Fund for Innovation
  • National Institutes of Health (K08EY030924)
  • Ghent University Special Research Fund (BOF15/GOA/011, BOF20/GOA/023)
  • National Eye Institute (P30 EY010572)
  • Las Madrinas Endowment in Experimental Therapeutics for Ophthalmology
  • Knights Templar Eye Foundation Endowment
  • NIHR Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology
  • Ghent University Hospital Innovation Fund (1802220N, 1803821N, NucleUZ)
  • Vision Health Research Network
  • Fondation Dalloz-Institut de France
  • Fighting Blindness Canada
  • Research to Prevent Blindness (Career Development Award, Unrestricted grant to the Casey Eye Institute, Unrestricted grant to the USC School of Medicine)
  • Yedidut Research Grant
  • Retina France
  • Welcome Trust (206619/Z/17/Z)
  • IRP-INSERM MYOPBYNIGHT
  • Foundation Fighting Blindness (BR-GE-0214-0639)
  • Indian Council of Medical Research and INSERM (53/1/Indo-Foreign/Oph/10-NCD-II)
  • Israel Science Foundation (2154/15)
  • Ministry of Health, State of Israel (300009177)

This publication has 33 references indexed in Scilit: